DOI: 10.4244/EIJV8I8A136

Statement on matching language to the type of evidence used in describing outcomes data

The Editors of the HEART Group Journals*

There are many different types of studies that can be conducted to provide evidence for clinical and outcomes research including, but not limited to, retrospective observational analyses, case-control studies and randomised controlled trials (RCTs). Each of these analyses has strengths and limitations, but most importantly, they all result in different types of conclusions about an intervention.

As illustrated in a series of examples provided in a separate review1, inappropriate word choice to describe results can lead to scientific inaccuracy. Therefore, the editors of the HEART Group (representing the world’s cardiovascular journals) recommend that all investigators and editors carefully select language to “match” the type of study conducted, without overstating findings or drawing erroneous conclusions about causality when they cannot be established.

As an illustrative example, when reporting results from an observational study that shows fewer deaths in one arm than in another, one should use descriptive statements such as, “the intervention is associated with lower mortality,” rather than definitive statements such as, “the intervention reduces mortality.” Conversely, when reporting the results of a rigorously conducted RCT with complete follow-up, in which the only difference captured between the two groups was the intervention, it may be appropriate to use somewhat more declarative statements such as, “the intervention reduced risk.” Additional examples of language matched with corresponding study type are listed in the Table 1.

In conclusion, all manuscripts should be written and edited not only for scientific accuracy but also for appropriateness of language used in describing the level of evidence provided by the study.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 8 Number 8
Dec 28, 2012
Volume 8 Number 8
View full issue


Key metrics

On the same subject

Editorial

10.4244/EIJ-E-24-00010 Apr 15, 2024
Timing of revascularisation in acute coronary syndromes with multivessel disease – two sides of the same coin
Stähli B and Stehli J
free

Editorial

10.4244/EIJ-E-24-00006 Apr 15, 2024
The miracle of left ventricular recovery after transcatheter aortic valve implantation
Dauerman H and Lahoud R
free

Research Correspondence

10.4244/EIJ-D-23-01046 Apr 15, 2024
Feasibility and safety of transcaval venoarterial extracorporeal membrane oxygenation in severe cardiogenic shock
Giustino G et al

State-of-the-Art

10.4244/EIJ-D-23-00836 Apr 15, 2024
Renal denervation in the management of hypertension
Lauder L et al
free

Original Research

10.4244/EIJ-D-23-00643 Apr 15, 2024
A study of ChatGPT in facilitating Heart Team decisions on severe aortic stenosis
Salihu A et al
Trending articles
338.63

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
295.45

Expert consensus

10.4244/EIJ-D-21-00898 Sep 20, 2022
Intravascular ultrasound guidance for lower extremity arterial and venous interventions
Secemsky E et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
149.53

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
103.48

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved